Unknown

Dataset Information

Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels.


ABSTRACT:

Background

China has a high incidence of esophageal cancer (EC), mainly squamous cell carcinoma, which is a serious threat to human life. Previous studies have shown that artemisinin can inhibit the proliferation and metastasis of cancer cells, thus inhibiting the progression of cancer. Aerobic glycolysis plays an important role in the uncontrolled growth of tumor cells. However, there are still different opinions on the anti-cancer mechanism, and there have been few studies involving EC. Our pre-experiment found that artemisinin can inhibit the progression of EC by directly regulating aerobic glycolysis.

Methods

The EC cell lines KYSE-150 and KYSE-170 were used to detect the effects of artemisinin on cell viability, proliferation, metastasis, and aerobic glycolysis. Network

SUBMITTER: Wang M 

PROVIDER: S-EPMC9660076 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature